SCHEMBL7111182

SCHEMBL7111182

CC(C)CN(C)c1ccc([N+](=O)[O-])c(N(Cl)C(=O)OC(C)(C)C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.35
ALDH1A1 P00352 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAPT P10636 3/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
AURKA O14965 1/20 0.33
RPS6KB1 P23443 1/20 0.33
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HCAR3 P49019 1/20 0.32
VCAM1 P19320 1/20 0.32
KDM4E B2RXH2 1/20 0.32
NPSR1 Q6W5P4 2/20 0.32
CYP2C19 P33261 2/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4453688 0.78 CETP (0.36) ALDH1A1SMN1; SMN2AURKARPS6KB1KMT2A
SCHEMBL14855272 0.76 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2MAPTL3MBTL1HCAR3
SCHEMBL7249303 0.75 NPSR1 (0.43) ALDH1A1MAPTNPSR1HTT
SCHEMBL6622345 0.74 AAK1 (0.31)
SCHEMBL14855451 0.72 MAPT (0.38) ALDH1A1SMN1; SMN2MAPTGAAMAPK1
SCHEMBL7039773 0.72 NR1H3 (0.33) ALDH1A1SMN1; SMN2GAAMAPK1CYP2C19
SCHEMBL1725199 0.71 MAPT (0.40) ALDH1A1MAPTHPGDKMT2AHCAR3
SCHEMBL12544792 0.70 GPR35 (0.33) ALDH1A1SMN1; SMN2MAPTGAAHPGD
SCHEMBL3247412 0.69 MAPK1 (0.43) ALDH1A1SMN1; SMN2MAPTMAPK1KMT2A
SCHEMBL5563667 0.68 PTGS2 (0.38) ALDH1A1GAAHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474416-A1 DIHYDROBENZODIAZEPIN-2-ONE-DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-10 EP disclosed
WO-2003066623-A1 DIHYDROBENZODIAZEPIN-2-ONE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 WO disclosed